ABSTRACT
Due to the limited availability of antifungal drugs, their relevant side effects and considering the insurgence of drug-resistant strains, novel antifungal agents are urgently needed. To identify such agents, we have developed an integrated computational and biological screening platform. We have considered a promising drug target in antifungal drug discovery (exo-1,3-ß-glucanase) and a phytochemical library composed of bioactive natural products was used. These products were computationally screened against the selected target using molecular docking and molecular dynamics techniques along with the evaluation of drug-like profile. We selected sesamin as the most promising phytochemical endowed with a potential antifungal profile and satisfactory drug-like properties. Sesamin was submitted to a preliminary biological evaluation to test its capability to inhibit the growth of several Candida species by calculating the MIC/MFC and conducting synergistic experiments with the marketed drug fluconazole. Following the screening protocol, we identified sesamin as a potential exo-1,3-ß-glucanase inhibitor, with relevant potency in inhibiting the growth of Candida species in a dose-dependent manner (MIC and MFC of 16 and 32 µg/mL, respectively). Furthermore, the combination of sesamin with fluconazole highlighted relevant synergistic effects. The described screening protocol revealed the natural product sesamin as a potential novel antifungal agent, showing an interesting predicted pharmacological profile, paving the way to the development of innovative therapeutics against fungal infections. Notably, our screening protocol can be helpful in antifungal drug discovery.
Subject(s)
Antifungal Agents , Sesamum , Antifungal Agents/pharmacology , Antifungal Agents/chemistry , Fluconazole/pharmacology , Molecular Docking Simulation , Glucan 1,3-beta-Glucosidase/pharmacology , Microbial Sensitivity Tests , Candida , Phytochemicals/pharmacology , Drug Resistance, FungalABSTRACT
Biological (or reductive) soil disinfestation (BSD or RSD) is a bioremediation process to control soil-borne plant pathogens using activities of indigenous bacteria in the soil. Three obligate anaerobic bacterial strains (TW1, TW10, and TB10), which were isolated from anoxic soil subjected to BSD treatments, were examined for their abilities to produce anti-fungal enzymes. All strains were affiliated with the different lineages of the genus Clostridium. The three strains decomposed ß-1,3-glucans (curdlan and laminarin), and ß-1,3-glucanase activities were detected from their culture supernatants with these glucans. The three strains also produced the enzyme with wheat bran as a growth substrate and killed the Fusarium pathogen (Fusarium oxysporum f. sp. spinaciae) in the anaerobic co-incubation conditions. Observation by fluorescence microscopy of the pathogen cells showed that the three strains had degraded the fungal cells in different manners upon co-incubation with wheat bran. When the three strains were cultivated with the dead cells or the cell wall samples prepared from the Fusarium pathogen, strain TW1 utilized these materials as easily decomposable substrates by releasing ß-1,3-glucanase. When observed by fluorescence microscopy, it appeared that strain TW1 degraded the mycelial cell wall nearly thoroughly, with the septa remaining as undecomposed luminous rings. In contrast, the other two strains decomposed neither the dead cells nor the cell wall samples directly. The results indicate that the various anaerobic bacteria proliferated in the soil under the BSD treatments should play key roles as an organized bacterial community to eliminate fungal pathogens, namely by release of anti-fungal enzymes with different properties.Key pointsâ¢Three clostridial strains isolated from BSD-treated soils produced ß-1,3-glucanase.â¢All strains killed the Fusarium pathogen in the anaerobic co-incubation conditions.â¢One of the strains produced ß-1,3-glucanase with the fungal cell wall as a substrate.â¢The strain degraded the cell wall almost completely, except for the mycelial septa.
Subject(s)
Clostridium/enzymology , Fungi/drug effects , Fungicides, Industrial/pharmacology , Glucan 1,3-beta-Glucosidase/biosynthesis , Soil Microbiology , Agriculture/methods , Bacteria, Anaerobic/classification , Bacteria, Anaerobic/enzymology , Clostridium/classification , Disinfection , Glucan 1,3-beta-Glucosidase/pharmacology , Phylogeny , Plant Diseases/microbiology , Plant Diseases/prevention & control , Soil/chemistryABSTRACT
Antimicrobial Photodynamic Therapy (aPDT) has been proposed as a means to treat Candida infections. However, microorganisms in biofilms are less susceptible to aPDT than planktonic cultures, possibly because the matrix limits the penetration of the photosensitizer. Therefore, the goals here were: (1) to target biofilm matrix components of a fluconazole-susceptible (S) and a fluconazole-resistant (R) C. albicans (Ca) strains using the hydrolytic enzymes ß-glucanase and DNase individually or in combination; (2) to apply the best enzyme protocol in association with aPDT mediated by Photodithazine® (PDZ); (3) to verify under confocal microscope the penetration of PDZ in biofilms pre-treated or not with DNase at different periods of incubation. CaS and CaR 48h-old biofilms were incubated with the hydrolytic enzymes (5â¯min) and evaluated by cell viability, biomass, and matrix components. DNase showed the best outcomes by significantly reducing extracellular DNA (eDNA) and soluble proteins from the matrix of both strains; and water-soluble polysaccharides from CaR matrix. Subsequently, 48h-old biofilms were incubated with DNase for 5â¯min, followed by incubation with PDZ for 20â¯min and exposure to LED light (660â¯nm, 50â¯J/cm²). Controls were biofilms treated only with aPDT without DNase, PDZ only, PDZâ¯+â¯DNase, light only, lightâ¯+â¯DNase, and biofilm without treatment. Pre-treatment with DNase allowed PDZ penetration into deeper biofilm layers, and the aPDT effect was enhanced, showing a significant reduction of the cell viability (pâ¯=â¯0.000) and eDNA amounts (pâ¯≤â¯0.047). DNase affected the matrix composition improving the penetration of the photosensitizer, thereby, improving the effectiveness of subsequent aPDT.
Subject(s)
Candida albicans/drug effects , Deoxyribonucleases/pharmacology , Glucan 1,3-beta-Glucosidase/pharmacology , Glucosamine/analogs & derivatives , Photochemotherapy/methods , Photosensitizing Agents/pharmacology , Biofilms , Drug Resistance, Fungal/drug effects , Fluconazole/pharmacology , Glucosamine/pharmacology , Microbial Viability/drug effects , Time FactorsABSTRACT
A novel ß-1,3-glucanase from Arca inflata was purified using chromatography methods. It was determined as a glycoprotein comprising 23.65% carbohydrate content with O-linked glycan and showed specific activity of 90.01⯱â¯1.2â¯U/mg against laminarin. The optimal pH and temperature for the activity of the glucanase were 6.0 and 40⯰C, respectively. The affinity parameter of the glucanase using laminarin was determined as Kdâ¯=â¯13.09⯵M. The activity of the glucanase was 27⯱â¯2.6% enhanced by 2-mM Mn2+ ions and inhibited by 40-50% using 2-mM Zn2+, Cu2+, or Ba2+ ions. The glucanase showed an endo-type cleavage mode and hydrolyzed laminarin into glucoses, disaccharides, trioligosaccharides, and tetraoligosaccharides. Otherwise, the glucanase exhibited immune-enhancing effects via significantly increasing the phagocytic activity of macrophages and inducing the release of nitric oxide, tumor necrosis factor α, and interleukin-6 in RAW264.7 cells. It might be used as a bifunctional additive for the food industry.
Subject(s)
Bivalvia/enzymology , Glucan 1,3-beta-Glucosidase/isolation & purification , Glucan 1,3-beta-Glucosidase/pharmacology , Immunologic Factors/isolation & purification , Immunologic Factors/pharmacology , Animals , Glucan 1,3-beta-Glucosidase/metabolism , Glucans/metabolism , Hydrogen-Ion Concentration , Hydrolysis , Immunologic Factors/metabolism , Macrophages/drug effects , Macrophages/immunology , Macrophages/metabolism , Mice , RAW 264.7 Cells , Substrate Specificity , TemperatureABSTRACT
Prophenoloxidase (proPO) activating system is an important immune response for arthropods. ß-1, 3-glucanase related protein (previously named as lipopolysaccharide and ß-1, 3-glucan binding protein (LGBP) in crustaceans) is a typical pattern recognition receptor family involved in the proPO activation by recognizing the invading microbes. In this study, we pay special attention to a bacteria-induced ß-1,3-glucanase related protein from red swamp crayfish Procambarus clarkii, an important aquaculture specie in China. This protein, designated PcBGRP, was found a typical member of crustacean BGRP family with the glucanase-related domain and the characteristic motifs. PcBGRP was expressed in hemcoyes and hepatopancreas, and its expression could be induced by the carbohydrate and bacteria stimulants. The induction by lipopolysaccharide (LPS) and ß-1,3-glucan (ßG) was more significant than by peptidoglycan (PG). The response of PcBGRP to the native Gram-negative bacterial pathogen Aeromonas hydrophila was more obvious than to Gram-positive bacteria. Using RNA interference and recombinant protein, PcBGRP was found to protect crayfish from A. hydrophila infection revealed by the survival test and morphological analysis. A mechanism study found PcBGRP could bind LPS and ßG in a dose-dependent manner, and the LPS recognizing ability determined the Gram-negative bacterium binding activity of PcBGRP. PcBGRP was found to enhance the PO activation both in vitro and in vivo, and the protective role was related to the PO activating ability of PcBGRP. This study emphasized the role of BGRP family in crustacean immune response, and provided new insight to the immunity of red swamp crayfish which suffered serious disease during the aquaculture in China.
Subject(s)
Arthropod Proteins/immunology , Astacoidea/immunology , Carrier Proteins/immunology , Gram-Negative Bacterial Infections/immunology , Staphylococcal Infections/immunology , Aeromonas hydrophila , Amino Acid Sequence , Animals , Arthropod Proteins/genetics , Astacoidea/genetics , Carrier Proteins/genetics , Glucan 1,3-beta-Glucosidase/pharmacology , Gram-Negative Bacterial Infections/genetics , Gram-Negative Bacterial Infections/veterinary , Hemocytes/immunology , Hepatopancreas/immunology , Lipopolysaccharides/pharmacology , Open Reading Frames , Peptidoglycan/pharmacology , Staphylococcal Infections/genetics , Staphylococcal Infections/veterinary , Staphylococcus aureusABSTRACT
ß-1,3-glucan plays a role in non-albicans Candida species biofilm formation and survival of biofilm Candida to stresses. In this study, we evaluated the antibiofilm activity of ß-1,3-glucanase, which can degrade poly-ß(1 â 3)-glucose of non-albicans Candida species biofilms, on single and mixed species biofilm of non-albicans Candida species, including Candida tropicalis, Candida parapsilosis and Candida krusei. Biofilm by all tested species in microplate were dispersed more than 60%. ß-1,3-glucanase also detached mixed species biofilm in microplate and on medical material surface. ß-1,3-glucanase had no effect on Candida planktonic growth as well as adhesion. However, further biofilm formation was inhibited with ß-1,3-glucanase added at 24 h after biofilm initiation. ß-1,3-glucanase markedly enhanced the antifungal susceptibility of amphotericin B. The examination using confocal laser scanning microscopy and scanning electron microscope confirmed the antibiofilm activity of ß-1,3-glucanase. Our findings demonstrate that ß-1,3-glucanase may be useful as an antibiofilm agent.
Subject(s)
Antifungal Agents/pharmacology , Biofilms/drug effects , Candida/drug effects , Glucan 1,3-beta-Glucosidase/pharmacology , Amphotericin B/pharmacology , Biofilms/growth & development , Candida parapsilosis/drug effects , Candida tropicalis/drug effects , Cell Communication/drug effects , Coculture Techniques , Drug Combinations , Microbial Sensitivity Tests , Microscopy, Confocal , Microscopy, Electron, Scanning , beta-Glucans/metabolismABSTRACT
A novel ß-1,3-glucanase gene, designated Ccglu17A, was cloned from the biological control fungus Chaetomium cupreum Ame. Its 1626-bp open reading frame encoded 541 amino acids. The corresponding amino acid sequence showed highest identity (67 %) with a glycoside hydrolase family 17 ß-1,3-glucanase from Chaetomium globosum. The recombinant protein Ccglu17A was successfully expressed in Pichia pastoris, and the enzyme was purified to homogeneity with 10.1-fold purification and 47.8 % recovery yield. The protein's molecular mass was approximately 65 kDa, and its maximum activity appeared at pH 5.0 and temperature 45 °C. Heavy metal ions Fe2+, Mn2+, Cu2+, Co2+, Ag+, and Hg2+ had inhibitory effects on Ccglu17A, but Ba2+ promoted the enzyme's activity. Ccglu17A exhibited high substrate specificity, almost exclusively catalyzing ß-1,3-glycosidic bond cleavage in various polysaccharoses to liberate glucose. The enzyme had a Km of 2.84 mg/mL and Vmax of 10.7 µmol glucose/min/mg protein for laminarin degradation under optimal conditions. Ccglu17A was an exoglucanase with transglycosylation activity based on its hydrolytic properties. It showed potential antifungal activity with a degradative effect on cell walls and inhibitory action against the germination of pathogenic fungus. In conclusion, Ccglu17A is the first functional exo-1,3-ß-glucanase to be identified from C. cupreum and has potential applicability in industry and agriculture.
Subject(s)
Antifungal Agents/chemistry , Chaetomium/enzymology , Fungal Proteins/metabolism , Glucan 1,3-beta-Glucosidase/metabolism , Glucans/metabolism , Antifungal Agents/metabolism , Antifungal Agents/pharmacology , Cations, Divalent , Chaetomium/chemistry , Chaetomium/classification , Cloning, Molecular , Fungal Proteins/genetics , Fungal Proteins/pharmacology , Fusarium/drug effects , Fusarium/growth & development , Gene Expression , Glucan 1,3-beta-Glucosidase/genetics , Glucan 1,3-beta-Glucosidase/pharmacology , Glucans/chemistry , Hydrogen-Ion Concentration , Kinetics , Metals, Heavy/chemistry , Molecular Weight , Open Reading Frames , Phylogeny , Pichia/genetics , Pichia/metabolism , Plasmids/chemistry , Plasmids/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Spores, Fungal/drug effects , Spores, Fungal/growth & development , Substrate SpecificityABSTRACT
Trichoderma spp. have been reported to aid in imparting biotic as well as abiotic tolerance to plants. However, there are only few reports unfolding the differential ability of separate species of Trichoderma genera generally exploited for their biocontrol potential in this framework. A study was undertaken to evaluate the biocontrol potential of different Trichoderma species namely T. harzianum, T. asperellum, T. koningiopsis, T. longibrachiatum, and T. aureoviride as identified in the group of indigenous isolates from the agricultural soils of Eastern Uttar Pradesh, India. Their biocontrol potential against three major soilborne phytopathogens, i.e., Sclerotium rolfsii, Sclerotinia sclerotiorum, and Colletotrichum capsici was confirmed by dual culture plate technique. Efficient mycoparasitic ability was further assessed in all the isolates in relation to chitinase, ß-1,3 glucanase, pectinase, lipase, amylase, and cellulase production while equally consistent results were obtained for their probable phosphate solubilization and indole acetic acid (IAA) production abilities. The selected isolates were further subjected to test their ability to promote plant growth, to reduce disease incidence and to tolerate biotic stress in terms of lignification pattern against S. rolfsii in chickpea plants. Among the identified Trichoderma species, excellent results were observed for T. harzianum and T. koningiopsis indicating better biocontrol potential of these species in the group and thus exhibiting perspective for their commercial exploitation.
Subject(s)
Antibiosis , Ascomycota/physiology , Basidiomycota/physiology , Cicer/growth & development , Cicer/microbiology , Pest Control, Biological , Trichoderma/physiology , Amylases/metabolism , Ascomycota/pathogenicity , Basidiomycota/pathogenicity , Cellulase/metabolism , Chitinases/biosynthesis , Chitinases/pharmacology , Colletotrichum/pathogenicity , Colletotrichum/physiology , Glucan 1,3-beta-Glucosidase/biosynthesis , Glucan 1,3-beta-Glucosidase/pharmacology , India , Indoleacetic Acids/metabolism , Lignin/metabolism , Lipase/metabolism , Phylogeny , Plants/metabolism , Plants/microbiology , Plants/ultrastructure , Polygalacturonase/metabolism , Soil Microbiology , Trichoderma/classification , Trichoderma/genetics , Trichoderma/isolation & purificationABSTRACT
In this work, we identified a gene from Theobroma cacao L. genome and cDNA libraries, named TcGlu2, that encodes a ß-1,3-1,4-glucanase. The TcGlu2 ORF was 720 bp in length and encoded a polypeptide of 239 amino acids with a molecular mass of 25.58 kDa. TcGlu2 contains a conserved domain characteristic of ß-1,3-1,4-glucanases and presented high protein identity with ß-1,3-1,4-glucanases from other plant species. Molecular modeling of TcGlu2 showed an active site of 13 amino acids typical of glucanase with ß-1,3 and 1,4 action mode. The recombinant cDNA TcGlu2 obtained by heterologous expression in Escherichia coli and whose sequence was confirmed by mass spectrometry, has a molecular mass of about 22 kDa (with His-Tag) and showed antifungal activity against the fungus Moniliophthora perniciosa, causal agent of the witches' broom disease in cacao. The integrity of the hyphae membranes of M. perniciosa, incubated with protein TcGlu2, was analyzed with propidium iodide. After 1 h of incubation, a strong fluorescence emitted by the hyphae indicating the hydrolysis of the membrane by TcGlu2, was observed. To our knowledge, this is the first study of a cacao ß-1,3-1,4-glucanase expression in heterologous system and the first analysis showing the antifungal activity of a ß-1,3-1,4-glucanase, in particular against M. perniciosa.
Subject(s)
Agaricales/drug effects , Cacao/enzymology , Glucan 1,3-beta-Glucosidase/pharmacology , Models, Molecular , Mycelium/drug effects , Recombinant Proteins/pharmacology , Agaricales/growth & development , Cacao/microbiology , Escherichia coli , Fluorescence , Glucan 1,3-beta-Glucosidase/genetics , Mass Spectrometry , Mycelium/growth & development , Propidium , Recombinant Proteins/geneticsABSTRACT
A strain of Streptomyces cavourensis subsp. cavourensis (coded as SY224) antagonistic to Colletotrichum gloeosporioides infecting pepper plants was isolated. SY224 produced lytic enzymes such as chitinase, beta-1,3-glucanase, lipase, and protease in respective assays. To examine for antifungal activity, the treatments amended with the nonsterilized supernatant resulted in the highest growth inhibition rate of about 92.9% and 87.4% at concentrations of 30% and 10%, respectively. However, the sterilized treatments (autoclaved or chloroform treated) gave a lowered but significant inhibitory effect of about 63.4% and 62.6% for the 10% supernatant concentration, and 75.2% and 74.8% for the of 30% supernatant concentration in the PDA agar medium, respectively, indicative of the role of a nonprotein, heat stable compound on the overall effect. This antifungal compound, which inhibited spore germination and altered hyphal morphology, was extracted by EtOAc and purified by ODS, silica gel, Sephadex LH-20 column, and HPLC, where an active fraction was confirmed to be 2-furancarboxaldehyde by GS-CI MS techniques. These results suggested that SY224 had a high potential in the biocontrol of anthracnose in pepper, mainly due to a combined effect of lytic enzymes and a non-protein, heatstable antifungal compound, 2-furancarboxaldehyde.
Subject(s)
Biological Control Agents , Capsicum/microbiology , Chitinases/isolation & purification , Glucan 1,3-beta-Glucosidase/isolation & purification , Plant Diseases/prevention & control , Streptomyces/enzymology , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Antifungal Agents/pharmacology , Bacterial Proteins/chemistry , Bacterial Proteins/isolation & purification , Bacterial Proteins/pharmacology , Chitin/chemistry , Chitinases/chemistry , Chitinases/pharmacology , Chloroform/pharmacology , Chromatography, High Pressure Liquid , Colletotrichum/drug effects , Colletotrichum/growth & development , Colletotrichum/pathogenicity , Enzyme Activation , Furans/chemistry , Furans/isolation & purification , Furans/pharmacology , Gas Chromatography-Mass Spectrometry/methods , Glucan 1,3-beta-Glucosidase/chemistry , Glucan 1,3-beta-Glucosidase/pharmacology , Hyphae/drug effects , Hyphae/growth & development , Lipase/chemistry , Lipase/pharmacology , Microbial Sensitivity Tests , Plant Diseases/microbiology , Silica Gel/chemistry , Spores, Fungal/drug effects , Spores, Fungal/growth & development , Streptomyces/chemistry , Streptomyces/isolation & purificationABSTRACT
The opportunistic fungus Candida albicans causes oral thrush and vaginal candidiasis, as well as candidaemia in immunocompromised patients including those undergoing cancer chemotherapy, organ transplant and those with AIDS. We previously found that the AMPs (antimicrobial peptides) LL37 and hBD-3 (human ß-defensin-3) inhibited C. albicans viability and its adhesion to plastic. For the present study, the mechanism by which LL37 and hBD-3 reduced C. albicans adhesion was investigated. After AMP treatment, C. albicans adhesion to plastic was reduced by up to ~60% and was dose-dependent. Our previous study indicated that LL37 might interact with the cell-wall ß-1,3-exoglucanase Xog1p, which is involved in cell-wall ß-glucan metabolism, and consequently the binding of LL37 or hBD-3 to Xog1p might cause the decrease in adhesion. For the present study, Xog1p(41-438)-6H, an N-terminally truncated, active, recombinant construct of Xog1p and Xog1p fragments were produced and used in pull-down assays and ELISA in vitro, which demonstrated that all constructs interacted with both AMPs. Enzymatic analyses showed that LL37 and hBD-3 enhanced the ß-1,3-exoglucanase activity of Xog1p(41-438)-6H approximately 2-fold. Therefore elevated Xog1p activity might compromise cell-wall integrity and decrease C. albicans adhesion. To test this hypothesis, C. albicans was treated with 1.3 µM Xog1p(41-438)-6H and C. albicans adhesion to plastic decreased 47.7%. Taken together, the evidence suggests that Xog1p is one of the LL37/hBD-3 targets, and elevated ß-1,3-exoglucanase activity reduces C. albicans adhesion to plastic.
Subject(s)
Candida albicans/physiology , Cathelicidins/physiology , Fungal Proteins/metabolism , Glucan 1,3-beta-Glucosidase/metabolism , beta-Defensins/physiology , Antimicrobial Cationic Peptides , Candida albicans/genetics , Candida albicans/growth & development , Candida albicans/metabolism , Cathelicidins/genetics , Cathelicidins/metabolism , Cathelicidins/pharmacology , Cell Adhesion/drug effects , Cell Adhesion/genetics , Cell Wall/drug effects , Cell Wall/genetics , Cell Wall/metabolism , Cytotoxins/genetics , Cytotoxins/metabolism , Cytotoxins/pharmacology , Cytotoxins/physiology , Dose-Response Relationship, Drug , Down-Regulation , Drug Evaluation, Preclinical , Fungal Proteins/genetics , Fungal Proteins/pharmacology , Fungal Proteins/physiology , Glucan 1,3-beta-Glucosidase/genetics , Glucan 1,3-beta-Glucosidase/pharmacology , Glucan 1,3-beta-Glucosidase/physiology , Humans , Microbial Sensitivity Tests , Organisms, Genetically Modified , Plastics , Protein Binding/genetics , beta-Defensins/genetics , beta-Defensins/metabolism , beta-Defensins/pharmacologyABSTRACT
An excessive production of vasoactive and proinflammatory bradykinin-related peptides, the kinins, is often involved in the human host defense against microbial infections. Recent studies have shown that a major fungal pathogen to humans, Candida albicans, can bind the proteinaceous kinin precursor, the high molecular weight kininogen (HK) and trigger the kinin-forming cascade on the cell surface. In this work, we preliminarily characterized a molecular mechanism underlying the HK adhesion to the fungal surface by (i) identification of major kininogen-binding constituents on the candidial cell wall and (ii) mapping the cell wall-binding regions on HK molecule. A major fraction of total fungal kininogen-binding capacity was assigned to ß-1,3-glucanase-extractable cell wall proteins (CWP). By adsorption of CWP on HK-coupled agarose gel and mass spectrometric analysis of the eluted material, major putative HK receptors were identified, including Als3 adhesin and three glycolytic enzymes, i.e., enolase 1, phosphoglycerate mutase 1 and triosephosphate isomerase 1. Using monoclonal antibodies directed against selected parts of HK molecule and synthetic peptides with sequences matching selected HK fragments, we assigned the major fungal cell wall-binding ability to a short stretch of amino acids in the C-terminal part of domain 3 and a large continuous region involving the C-terminal part of domain 5 and N-terminal part of domain 6 (residues 479-564). The latter characteristics of HK binding to C. albicans surface differ from those reported for bacteria and host cells.
Subject(s)
Candida albicans/metabolism , Cell Wall/metabolism , Kininogen, High-Molecular-Weight/metabolism , Protein Interaction Mapping/methods , Amino Acid Sequence , Antibodies, Monoclonal/metabolism , Binding Sites , Candida albicans/drug effects , Candida albicans/enzymology , Cell Wall/drug effects , Electrophoresis, Polyacrylamide Gel , Fungal Proteins/metabolism , Glucan 1,3-beta-Glucosidase/pharmacology , Humans , Hyphae/drug effects , Hyphae/metabolism , Mass Spectrometry , Molecular Sequence Data , Peptide Fragments/metabolism , Phosphoglycerate Mutase/metabolism , Phosphopyruvate Hydratase/chemistry , Protein Binding , Protein Structure, Tertiary , Receptors, Cell Surface/metabolism , Triose-Phosphate Isomerase/metabolismABSTRACT
The use of cell wall degrading enzymes from Trichoderma asperellum immobilized on biodegradable support is an alternative for food packaging. In this study, hydrolytic enzymes produced by T. asperellum were tested as a fungal growth inhibitor, in free form or immobilized on a biodegradable film composed of cassava starch and poly(butylene adipate-co-terephtalate) (PBAT). The inhibitory activity was tested against Aspergillus niger , Penicillium sp., and Sclerotinia sclerotiorum , microorganisms that frequently degrade food packaging. The use of chitin as carbon source in liquid medium induced T. asperellun to produce N-acetylglucosaminidase, ß-1,3-glucanase, chitinase, and protease. The presence of T. asperellun cell wall degradating enzymes (T-CWD) immobilized by adsorption or covalent attachment resulted in effective inhibition of fungal growth. The enzymatic activity of T-CWD was stronger on S. sclerotiorum than on the Aspergillus or Penicillum isolates tested. These results suggest that T-CWD can be used in a free or immobilized form to suppress fungi that degrade food packaging.
Subject(s)
Acetylglucosaminidase/pharmacology , Antifungal Agents/pharmacology , Chitinases/pharmacology , Enzymes, Immobilized/pharmacology , Fungal Proteins/pharmacology , Fungi/drug effects , Glucan 1,3-beta-Glucosidase/pharmacology , Trichoderma/enzymology , Acetylglucosaminidase/chemistry , Antifungal Agents/chemistry , Cell Wall/drug effects , Chitinases/chemistry , Enzymes, Immobilized/chemistry , Food Packaging , Food Preservation , Fungal Proteins/chemistry , Fungi/growth & development , Glucan 1,3-beta-Glucosidase/chemistry , Hydrolysis , Trichoderma/chemistryABSTRACT
A possibility of adhesion inhibition of Corynebacterium diphtheriae to human buccal epithelium by glycoside hydrolases of marine hydrobiontes was investigated using alpha-galactosidase from marine bacterium Pseudoalteromonas sp. KMM 701, total enzyme preparation and beta-1,3-glucanase from marine fungi Chaetomium, total enzyme preparation and beta-1,3-glucanase from marine mollusk Littorina kurila, and total enzyme preparation from crystalline style of marine mollusk Spisula sachalinensis were used. The enzymes were added to test-tubes containing buccal epithelial cells and/or the toxigenic bacterial strain C. diphtheriae No 1129, v. gravis. All the investigated enzymes were able to abort C. diphtheriae adherence, to human buccal epithelocytes. Inhibition of adhesion was more pronounced in the case of treatment of epithelocytes with highly purified enzymes of marine hydrobiontes in comparison with total enzyme preparations. The significant inhibition of C. diphtheriae adhesion was observed when the enzymes were added to the epithelocytes with the attached microorganisms. The results obtained show that glycoside hydrolases of marine hydrobiontes degrade any carbohydrates expressed on cell surface of bacterium or human buccal epithelocytes, impair unique lectin-carbohydrate interaction and prevent the adhesion.
Subject(s)
Bacterial Adhesion , Corynebacterium diphtheriae/physiology , Glycoside Hydrolases/pharmacology , Mouth Mucosa/drug effects , Animals , Chaetomium/enzymology , Crustacea/enzymology , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Glucan 1,3-beta-Glucosidase/isolation & purification , Glucan 1,3-beta-Glucosidase/pharmacology , Glycoside Hydrolases/isolation & purification , Humans , In Vitro Techniques , Mouth Mucosa/microbiology , Pseudoalteromonas/enzymology , Spisula/enzymology , alpha-Galactosidase/isolation & purification , alpha-Galactosidase/pharmacologyABSTRACT
A wheat beta-1,3-glucanase gene (TaGluD) was identified as a fungal defense candidate. Its transcript induction was more than 60-fold higher in a resistant wheat line, Shannong0431, than in a susceptible wheat line, Wenmai6, after infection with Rhizoctonia cerealis. The TaGluD protein was overexpressed as inclusion bodies in Escherichia coli. After refolding and purification, TaGluD with 1 unit of beta-1,3-glucanase showed antifungal activity in vitro against Rhizoctonia solani, R. cerealis, Phytophthora capsici and Alternaria longipes with inhibition rates of 42%, 43%, 32% and 30%, respectively. Thus TaGluD may be useful for enhancing fungal resistance in several crop species.
Subject(s)
Alternaria/drug effects , Antifungal Agents/pharmacology , Glucan 1,3-beta-Glucosidase/pharmacology , Phytophthora/drug effects , Rhizoctonia/drug effects , Triticum/enzymology , Antifungal Agents/isolation & purification , Cloning, Molecular , Escherichia coli/genetics , Gene Expression , Gene Expression Profiling , Glucan 1,3-beta-Glucosidase/isolation & purificationABSTRACT
Previously, we isolated a strain of Bacillus that had antifungal activity and produced lytic enzymes with fungicidal potential. In the present study, we identified the bacterium as Paenibacillus ehimensis and further explored its antifungal properties. In liquid co-cultivation assays, P. ehimensis IB-X-b decreased biomass production of several pathogenic fungi by 45%-75%. The inhibition was accompanied by degradation of fungal cell walls and alterations in hyphal morphology. Residual medium from cultures of P. ehimensis IB-X-b inhibited fungal growth, indicating the inhibitors were secreted into the medium. Of the 2 major lytic enzymes, chitinases were only induced by chitin-containing substrates, whereas beta-1,3-glucanase showed steady levels in all carbon sources. Both purified chitinase and beta-1,3-glucanase degraded cell walls of macerated fungal mycelia, whereas only the latter also degraded cell walls of intact mycelia. The results indicate synergism between the antifungal action mechanisms of these enzymes in which beta-1,3-glucanase is the initiator of the cell wall hydrolysis, whereas the degradation process is reinforced by chitinases. Paenibacillus ehimensis IB-X-b has pronounced antifungal activity with a wide range of fungi and has potential as a biological control agent against plant pathogenic fungi.
Subject(s)
Antifungal Agents/pharmacology , Bacillus/enzymology , Chitinases/pharmacology , Fungi/drug effects , Glucan 1,3-beta-Glucosidase/pharmacology , Soil Microbiology , Antibiosis , Antifungal Agents/isolation & purification , Antifungal Agents/metabolism , Bacillus/genetics , Bacillus/isolation & purification , Bacillus/physiology , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Bacterial Proteins/metabolism , Bacterial Proteins/pharmacology , Cell Wall/drug effects , Chitinases/genetics , Chitinases/isolation & purification , Chitinases/metabolism , Fungi/growth & development , Glucan 1,3-beta-Glucosidase/genetics , Glucan 1,3-beta-Glucosidase/isolation & purification , Glucan 1,3-beta-Glucosidase/metabolism , Mycelium/drug effects , Mycelium/growth & development , Plant Diseases/microbiologyABSTRACT
The molecular mass of the purified killer toxin from the marine killer yeast YF07b was estimated to be 47.0 kDa. The optimal pH and temperature of the purified killer toxin were 4.5 and 40 degrees C, respectively. The toxin was activated by Ca(2+), K(+), Na(+), Mg(2+), Na(+), and Co(2+). However, Fe(2+), Fe(3+), Hg(2+), Cu(2+), Mn(2+), Zn(2+), and Ag(+) acted as inhibitors in decreasing activity of the toxin. The toxin was strongly inhibited by phenylmethanesulphonyl fluoride (PMSF), iodoacetic acid, ethylenediaminetetraacetic acid, and 1,10-phenanthroline. The Km of the toxin for laminarin was 1.17 g L(-1). The toxin also actively hydrolyzed laminarin and killed the whole cells of the pathogenic yeast in crab.
Subject(s)
Brachyura/microbiology , Fungal Proteins/metabolism , Fungal Proteins/pharmacology , Pichia/metabolism , Yeasts/drug effects , Animals , Calcium/pharmacology , Catalysis/drug effects , Copper/pharmacology , Electrophoresis, Polyacrylamide Gel , Enzyme Activation/drug effects , Enzyme Stability , Fungal Proteins/chemistry , Glucan 1,3-beta-Glucosidase/chemistry , Glucan 1,3-beta-Glucosidase/metabolism , Glucan 1,3-beta-Glucosidase/pharmacology , Hydrogen-Ion Concentration , Iron/pharmacology , Killer Factors, Yeast , Kinetics , Manganese/pharmacology , Mercury/pharmacology , Molecular Weight , Potassium/pharmacology , Proteins/chemistry , Proteins/metabolism , Proteins/pharmacology , Silver/pharmacology , Sodium/pharmacology , Temperature , Yeasts/growth & development , Zinc/pharmacologyABSTRACT
Killer proteins that are produced and secreted into the environment by certain yeast strains are considered as promising antifungal agents. In this study, in vitro activity of Pichia anomala NCYC 434 (K5) killer protein, panomycocin, which is a 49 kDa glycoprotein with an exo-beta-1,3-glucanase activity was tested against 41 isolates of dermatophytes. Minimum inhibitory concentrations (MICs) were determined by a broth microdilution method based on the reference document M38-A of Clinical and Laboratory Standards Institute (CLSI; formerly NCCLS). For panomycocin MIC determinations two end point criteria MIC-2 (prominent growth inhibition) and MIC-0 (complete growth inhibition) were recorded. All the tested isolates (Microsporum spp. and Trichophyton spp.) were found susceptible to panomycocin. The MIC-2 values ranged from 0.25 to 2 microg ml(-1) and MIC-0 values ranged from 1 to 8 microg ml(-1). These results showed that panomycocin is active in vitro against fungal strains that cause superficial infections and highlighted its probable use as a topical antifungal agent.
Subject(s)
Antifungal Agents/pharmacology , Arthrodermataceae/drug effects , Glucan 1,3-beta-Glucosidase/pharmacology , Pichia/enzymology , Antifungal Agents/isolation & purification , Antifungal Agents/metabolism , Arthrodermataceae/classification , Glucan 1,3-beta-Glucosidase/isolation & purification , Glucan 1,3-beta-Glucosidase/metabolism , Microbial Sensitivity Tests/standards , Microsporum/classification , Microsporum/drug effects , Trichophyton/classification , Trichophyton/drug effectsABSTRACT
Chitosan is a plasma membrane-perturbing compound consisting of linear chains of beta-1,4-linked glucosamine residues, which at acidic pHs become positively charged. It is extensively used as an antimicrobial compound, yet its mode of action is still unresolved. Chitosan strongly affected the growth of the yeast Saccharomyces cerevisiae, the food spoilage yeast Zygosaccharomyces bailii, and two human-pathogenic yeasts, Candida albicans and Candida glabrata. Microarray analysis of yeast cells treated with sublethal concentrations of chitosan revealed induction of the environmental stress response and three more major transcriptional responses. The first was a rapid and stable Cin5p-mediated response. Cin5p/Yap4p is a transcription factor involved in various stress responses. Deletion of CIN5 led to increased chitosan sensitivity. The second was a Crz1p-mediated response, which is delayed compared to the Cin5p response. Crz1p is a transcription factor of the calcineurin pathway. Cells deleted for CRZ1 or treated with the calcineurin inhibitor FK506 became hypersensitive to chitosan, supporting the notion that the Crz1p-controlled response offers protection against chitosan. The third was a strong Rlm1p-mediated response which ran parallel in time with the Crz1p-regulated response. Rlm1p is a transcription factor of the cell wall integrity pathway, which is activated by cell wall stress. Importantly, chitosan-treated cells became more resistant to beta-1,3-glucanase, which is a well-known response to cell wall stress. We propose that the transcriptional response to chitosan may be representative of other plasma membrane-perturbing compounds.
Subject(s)
Cell Membrane/metabolism , Chitosan/pharmacology , Gene Expression Regulation, Fungal , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/genetics , Signal Transduction/drug effects , Transcription, Genetic , Apoptosis/drug effects , Calcineurin/pharmacology , Cell Membrane/chemistry , Cell Proliferation/drug effects , Cell Wall/chemistry , DNA-Binding Proteins , Drug Resistance, Fungal , Gene Expression Profiling , Glucan 1,3-beta-Glucosidase/pharmacology , MADS Domain Proteins , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Oligonucleotide Array Sequence Analysis , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Sequence Deletion , Tacrolimus/pharmacology , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , beta-Glucans/metabolismABSTRACT
Trichoderma is known for being the most frequently used biocontrol agent in agriculture. A fundamental part of the Trichoderma antifungal system relies on a series of genes coding for a variety of extracellular lytic enzymes. Characterization of the polymorphism between five putative isoenzymatic activities [beta-1,3-glucanase (EC 3.2.1.39, EC 3.2.1.58), beta-1,6-glucanase (EC 3.2.1.75), cellulase (EC 3.2.1.4; EC 3.2.1.21, EC 3.2.1.91), chitinase (EC 3.2.1.30, EC 3.2.1.52), protease (EC 3.4.11; EC 3.4.13-19; EC 3.4.21-24, EC 3.4.99)] was carried out using 18 strains from three sections of Trichoderma. Of these, seven strains were from T. sect. Pachybasium, nine from T. sect. Trichoderma and two from T. sect. Longibrachiatum. Thirty-seven different alleles in total were identified: 13 for beta-1,3-glucanase, four for beta-1,6-glucanase, three for cellulase, eight for chitinase and nine for protease activity. A dendrogram (constructed by the unweighted pair group method with arithmetic averages) based on isoenzymatic data separated the 18 strains into three main enzymatic groups: T. harzianum, T. atroviride/T. viride/T. koningii and T. asperellum/T. hamatum/T. longibrachiatum. Isoenzymatic groupings obtained from biocontrol strains are discussed in relation to their phylogenetic location, based on their sequence of internal transcribed spacer 1 in ribosomal DNA and their antifungal activities.